Proprietary IP Strain Genetics Licensing

---

FloraRX offers exclusive territorial licensing of our competition-proven, patent-protected strain portfolio with guaranteed 30%+ THCA potency that commands 20-25% royalties versus industry standards of 12-15%. Our 28-strain IP portfolio, valued between $28M-$112M, provides licensees with comprehensive cultivation support, quality protocols, and the competitive advantage of scientifically-validated genetics that consistently win industry awards. Each licensed strain comes with complete documentation, breeding methodologies, and exclusive territorial rights that create scarcity value and permanent pricing power in local markets.